🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in the Netherlands / NCT07110753
Recruiting Not applicable

The Effect of a Combined Lifestyle Intervention for Patients With Cancer on Quality of Life

NCT07110753 · tracked via the Priya Life Science Netherlands tracker
Phase
Not applicable
Started
2025-09-15
Last updated
2026-07-08

Condition(s) studied

Cancer

Investigational drug(s) / intervention(s)

combined lifestyle intervention focusing on various lifestyle components, delivered by a lifestyle coach and oncology nurseshort online lifestyle intervention by lifestyle coach and educational materials after 6 months

combined lifestyle intervention focusing on various lifestyle components, delivered by a lifestyle coach and oncology nurse: The combined lifestyle intervention focuses on various lifestyle components, including nutrition, physical activity, sleep, stress and sense of purpose, and is structured around the process of behaviour change. It is delivered by a lifestyle coach in collaboration with an oncology nurse.

short online lifestyle intervention by lifestyle coach and educational materials after 6 months: The control group receives 4 online group sessions from a lifestyle coach and all educational materials after 6 months of intervention

Study summary

A growing number of people are living with the (long-term) consequences of cancer and its treatment, which can negatively affect their quality of life. This study aims to assess the effect of a combined lifestyle intervention for patients with cancer on quality of life.

Eligibility

Sex
ALL
Min age
40 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Be diagnosed with an invasive or hematological cancer type and either within five years post-primary treatment with curative intent OR having advanced cancer (stage IV) with a prolonged life expectancy (chronic cancer patients) . Primary treatment in this context, includes among others surgery (\> 3 months ago), radiotherapy, and/or chemotherapy or a stem cell transplant in case of hematological cancers. * Report a reduced HRQoL, i.e., a low score on at least 2 of the functioning scales and/or the symptom scale fatigue of the EORTC-QLQ-30 based on the thresholds of clinical importance of Giesinger et al. (2020) * Be 40 years of age or older. The investigators have chosen this cut-off because they believe that younger cancer patients (AYA's) face different challenges and should not be mixed with the average older patient. This approach ensures greater homogeneity within the study population. * Be able to speak and understand Dutch Exclusion Criteria: * Following, or planned to follow a combined lifestyle intervention (i.e., one of the existing interventions for overweight) during the intervention period * Patients in the terminal phase (life expectancy \< 3 months) * Mental or behavioural problems that hinder participating in group lifestyle coaching indicated by the health care professional who is referring to GLINK or by the study team * Any circumstances that would impede ability to give informed consent or adherence to study requirements as determined by the study team or treating physician

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
UMC Utrecht Utrecht Utrecht Recruiting

More UMC Utrecht trials in the Netherlands

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07110753 on ClinicalTrials.gov ↗ ← All trials in the Netherlands